{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T23:06:04Z","timestamp":1785539164316,"version":"3.56.0"},"reference-count":20,"publisher":"Japanese Circulation Society","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ J"],"published-print":{"date-parts":[[2024,12,25]]},"DOI":"10.1253\/circj.cj-24-0205","type":"journal-article","created":{"date-parts":[[2024,9,2]],"date-time":"2024-09-02T22:14:37Z","timestamp":1725315277000},"page":"41-52","source":"Crossref","is-referenced-by-count":10,"title":["Medical Therapy and Clinical Outcomes in Cardiac Sarcoidosis Patients With Systolic Heart Failure"],"prefix":"10.1253","volume":"89","author":[{"given":"Daniel","family":"Sykora","sequence":"first","affiliation":[{"name":"Mayo Clinic School of Graduate Medical Education"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Bratcher","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Diseases, Mayo Clinic Rochester"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Churchill","sequence":"additional","affiliation":[{"name":"Mayo Clinic Alix School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. Michelle","family":"Kim","sequence":"additional","affiliation":[{"name":"Mayo Clinic Alix School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Elwazir","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Diseases, Mayo Clinic Rochester"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"Young","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Diseases, Mayo Clinic Rochester"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sami","family":"Ryan","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Diseases, Mayo Clinic Rochester"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikhil","family":"Kolluri","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Diseases, Mayo Clinic Rochester"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Abou Ezzeddine","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Diseases, Mayo Clinic Rochester"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Bois","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Diseases, Mayo Clinic Rochester"},{"name":"Department of Diagnostic Radiology, Mayo Clinic Rochester"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Giudicessi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Diseases, Mayo Clinic Rochester"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie","family":"Cooper","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Diseases, Mayo Clinic Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Rosenbaum","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Diseases, Mayo Clinic Rochester"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1. Rybicki BA, Major M, Popovich J, Maliarik MJ, Iannuzzi MC. Racial differences in sarcoidosis incidence: A 5-year study in a health maintenance organization. <i>Am J Epidemiol<\/i> 1997; 145: 234\u2013241, doi:10.1093\/oxfordjournals.aje.a009096.","DOI":"10.1093\/oxfordjournals.aje.a009096"},{"key":"2","doi-asserted-by":"publisher","unstructured":"2. Arkema EV, Grunewald J, Kullberg S, Eklund A, Askling J. Sarcoidosis incidence and prevalence: A nationwide register-based assessment in Sweden. <i>Eur Respir J<\/i> 2016; 48: 1690\u20131699, doi:10.1183\/13993003.00477-2016.","DOI":"10.1183\/13993003.00477-2016"},{"key":"3","doi-asserted-by":"publisher","unstructured":"3. Fussner LA, Karlstedt E, Hodge DO, Fine NM, Kalra S, Carmona EM, et al. Management and outcomes of cardiac sarcoidosis: A 20-year experience in two tertiary care centres. <i>Eur J Heart Fail<\/i> 2018; 20: 1713\u20131720, doi:10.1002\/ejhf.1319.","DOI":"10.1002\/ejhf.1319"},{"key":"4","doi-asserted-by":"publisher","unstructured":"4. Sadek MM, Yung D, Birnie DH, Beanlands RS, Nery PB. Corticosteroid therapy for cardiac sarcoidosis: A systematic review. <i>Can J Cardiol<\/i> 2013; 29: 1034\u20131041, doi:10.1016\/j.cjca.2013.02.004.","DOI":"10.1016\/j.cjca.2013.02.004"},{"key":"5","doi-asserted-by":"publisher","unstructured":"5. Yafasova A, Fosb\u00f8l EL, Schou M, Gustafsson F, Rossing K, Bundgaard H, et al. Long-term adverse cardiac outcomes in patients with sarcoidosis. <i>J Am Coll Cardiol<\/i> 2020; 76: 767\u2013777, doi:10.1016\/j.jacc.2020.06.038.","DOI":"10.1016\/j.jacc.2020.06.038"},{"key":"6","doi-asserted-by":"publisher","unstructured":"6. Terasaki F, Azuma A, Anzai T, Ishizaka N, Ishida Y, Isobe M, et al. JCS 2016 guideline on diagnosis and treatment of cardiac sarcoidosis: Digest version. <i>Circ J<\/i> 2019; 83: 2329\u20132388, doi:10.1253\/circj.CJ-19-0508.","DOI":"10.1253\/circj.CJ-19-0508"},{"key":"7","doi-asserted-by":"publisher","unstructured":"7. Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, et al. 2022 AHA\/ACC\/HFSA guideline for the management of heart failure: A report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. <i>Circulation<\/i> 2022; 145: e895\u2013e1032, doi:10.1161\/CIR.0000000000001063.","DOI":"10.1161\/CIR.0000000000001063"},{"key":"8","doi-asserted-by":"publisher","unstructured":"8. Birnie DH, Sauer WH, Bogun F, Cooper JM, Culver DA, Duvernoy CS, et al. HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis. <i>Hear Rhythm<\/i> 2014; 11: 1304\u20131323, doi:10.1016\/j.hrthm.2014.03.043.","DOI":"10.1016\/j.hrthm.2014.03.043"},{"key":"9","doi-asserted-by":"publisher","unstructured":"9. Rosenbaum AN, Kolluri N, Elwazir MY, Kapa S, Abou Ezzeddine OF, Bois JP, et al. Identification of a novel presumed cardiac sarcoidosis category for patients at high risk of disease. <i>Int J Cardiol<\/i> 2021; 335: 66\u201372, doi:10.1016\/j.ijcard.2021.04.022.","DOI":"10.1016\/j.ijcard.2021.04.022"},{"key":"10","doi-asserted-by":"publisher","unstructured":"10. Wen A, Fu S, Moon S, El Wazir M, Rosenbaum A, Kaggal VC, et al. Desiderata for delivering NLP to accelerate healthcare AI advancement and a Mayo Clinic NLP-as-a-service implementation. <i>NPJ Digit Med<\/i> 2019; 2: 130, doi:10.1038\/s41746-019-0208-8.","DOI":"10.1038\/s41746-019-0208-8"},{"key":"11","doi-asserted-by":"publisher","unstructured":"11. Khan MS, Chan PS, Sherrod CF, Ikemura N, Sauer AJ, Jones PG, et al. Generalizable approach to quantifying guideline-directed medical therapy. <i>Circ Heart Fail<\/i> 2024; 17: e011164, doi:10.1161\/CIRCHEARTFAILURE.123.011164.","DOI":"10.1161\/CIRCHEARTFAILURE.123.011164"},{"key":"12","doi-asserted-by":"publisher","unstructured":"12. Chareonthaitawee P, Beanlands RS, Chen W, Dorbala S, Miller EJ, Murthy VL, et al. Joint SNMMI\u2013ASNC expert consensus document on the role of <sup>18<\/sup>F-FDG PET\/CT in cardiac sarcoid detection and therapy monitoring. <i>J Nucl Med<\/i> 2017; 58: 1341\u20131353, doi:10.2967\/jnumed.117.196287.","DOI":"10.2967\/jnumed.117.196287"},{"key":"13","doi-asserted-by":"publisher","unstructured":"13. Christopoulos G, Jouni H, Acharya GA, Blauwet LA, Kapa S, Bois J, et al. Suppressing physiologic 18-fluorodeoxyglucose uptake in patients undergoing positron emission tomography for cardiac sarcoidosis: The effect of a structured patient preparation protocol. <i>J Nucl Cardiol<\/i> 2021; 28: 661\u2013671, doi:10.1007\/s12350-019-01746-4.","DOI":"10.1007\/s12350-019-01746-4"},{"key":"14","doi-asserted-by":"publisher","unstructured":"14. Sykora D, Young KA, Elwazir MY, Bois JP, Arment CA, Chareonthaitawee P, et al. The mechanism and natural history of mitral regurgitation in cardiac sarcoidosis. <i>Am J Cardiol<\/i> 2023; 191: 84\u201391, doi:10.1016\/j.amjcard.2023.01.002.","DOI":"10.1016\/j.amjcard.2023.01.002"},{"key":"15","doi-asserted-by":"publisher","unstructured":"15. Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. <i>J Biomed Inform<\/i> 2009; 42: 377\u2013381, doi:10.1016\/j.jbi.2008.08.010.","DOI":"10.1016\/j.jbi.2008.08.010"},{"key":"16","doi-asserted-by":"publisher","unstructured":"16. Harris PA, Taylor R, Minor BL, Elliott V, Fernandez M, O\u2019Neal L, et al. The REDCap consortium: Building an international community of software platform partners. <i>J Biomed Inform<\/i> 2019; 95: 103208, doi:10.1016\/j.jbi.2019.103208.","DOI":"10.1016\/j.jbi.2019.103208"},{"key":"17","doi-asserted-by":"publisher","unstructured":"17. Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, et al. 2009 Focused update incorporated into the ACC\/AHA 2005 Guidelines for the diagnosis and management of heart failure in adults: A report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines developed in collaboration with the International Society for Heart and Lung Transplantation. <i>J Am Coll Cardiol<\/i> 2009; 53: e1\u2013e90, doi:10.1016\/j.jacc.2008.11.013.","DOI":"10.1016\/j.jacc.2008.11.013"},{"key":"18","doi-asserted-by":"publisher","unstructured":"18. Zhou Y, Lower EE, Li HP, Costea A, Attari M, Baughman RP. Cardiac sarcoidosis: The impact of age and implanted devices on survival. <i>Chest<\/i> 2017; 151: 139\u2013148, doi:10.1016\/j.chest.2016.08.1457.","DOI":"10.1016\/j.chest.2016.08.1457"},{"key":"19","doi-asserted-by":"publisher","unstructured":"19. Samarendra P. GDMT for heart failure and the clinician\u2019s conundrum. <i>Clin Cardiol<\/i> 2019; 42: 1155\u20131161, doi:10.1002\/clc.23268.","DOI":"10.1002\/clc.23268"},{"key":"20","doi-asserted-by":"publisher","unstructured":"20. Vel\u00e1zquez H, Perazella MA, Wright FS, Ellison DH. Renal mchanism of timethoprim-induced hperkalemia. <i>Ann Intern Med<\/i> 1993; 119: 296\u2013301, doi:10.7326\/0003-4819-119-4-199308150-00008.","DOI":"10.7326\/0003-4819-119-4-199308150-00008"}],"container-title":["Circulation Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/89\/1\/89_CJ-24-0205\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,28]],"date-time":"2024-12-28T03:17:45Z","timestamp":1735355865000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/89\/1\/89_CJ-24-0205\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,25]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1253\/circj.cj-24-0205","relation":{},"ISSN":["1346-9843","1347-4820"],"issn-type":[{"value":"1346-9843","type":"print"},{"value":"1347-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,25]]},"article-number":"CJ-24-0205"}}